pre_text: NOTE 9 – CONTINGENT PURCHASE PRICE Our purchase of CareSpeak Communications contains a contingent element that will be paid only if the Company achieves certain patient engagement revenues in 2019 and 2020. The total contingent payment may be up to $3.0 million. The target patient engagement revenues were achieved in 2019 and are expected to be achieved in 2020. The calculated fair value of the contingent payment was $2,365,000 at December 31, 2018 and $3,000,000 at December 31, 2019. Our purchase of RMDY Health, Inc. also contains a contingent element that will be paid only if the Company achieves certain revenues in 2020 and 2021 related to the RMDY business. The total contingent payment may be up to $30.0 million. The minimum payment is $1.0 million in each of the two years. The calculated fair value of the contingent payment was $3,720,000 at December 31, 2019. We determined the fair value of the Contingent Purchase Price Payable at December 31, 2019 using a Geometric-Brownian motion analysis of the expected revenue and resulting earnout payment using inputs that include the spot price, a risk free rate of return of 1.4%, a term of 2 years, and volatility of 40%. Changes in the inputs could result in a different fair value measurement. The total fair value of contingent purchase price payable at December 31, 2019 is as follows.
table: Current Long-Term   Total 
table: CareSpeak Communications, Inc.  $1,500,000 $1,500,000 $3,000,000
table: RMDY Health, Inc.   - 3,720,000 3,720,000
table: Total  $1,500,000 $5,220,000 $6,720,000
question: Analyse this data from a financial earnings document. What is the proportion of total long-term fair value of contingent purchase price payable over total fair value of contingent purchase price payable?